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Purpose: To quantify the long-term outcomes of congenital glaucoma and surgical success rates 
following pseudo 360-degree trabeculotomy surgery at Children’s Medical Center in Dallas.
Patients and methods: An International Classification of Diseases (ICD-9) database was 
utilized for a retrospective chart review. Thirty-eight eyes of 24 who underwent primary trabe-
culotomy with a pseudo 360-degree technique between June 1, 1992 and December 31, 2005 
were studied.
Results: Mean age at the time of trabeculotomy was 11.1 ± 3.0 months, with seven eyes operated 
on after 1 year of age. Mean follow-up was 85.1 ± 9.0 months. Mean intraocular pressure (IOP) 
at the time of glaucoma diagnosis was 32.7 ± 1.1 mmHg, and final mean IOP for all eyes (after 
trabeculotomy and any additional surgery and/or glaucoma medications) was 17.9 ± 0.8 mmHg. 
With trabeculotomy and medication alone, mean final IOP was 19.9 ± 1.1 mmHg, with a mean 
drop in IOP of 12.5 ± 1.4 mmHg. Surgical success, defined by adequate IOP control, was achieved 
in 30 eyes (78.96%) at most recent follow-up. Kaplan–Meier analysis demonstrated 5- and 
10-year survival probabilities of 93.1% and 66.8%, respectively. Seventeen eyes (44.7% of all 
eyes) achieved complete success, meaning IOP control ,21 mmHg without additional medical 
therapy. All seventeen had primary congenital glaucoma (PCG); no eyes with aphakic glaucoma 
(AG) or Sturge–Weber syndrome (SWS) achieved complete success. Seven eyes (18.4%) failed 
primary trabeculotomy. Mean time to failure was 46.9 ± 8.6 months. Eyes with SWS had a 
significantly higher failure rate (P = 0.009) and a 5.81 relative risk of failure (P = 0.026).
Conclusions: Our long-term trabeculotomy success rates for congenital glaucoma compare 
favorably with existing reports in the literature. Eyes with AG and SWS may warrant consid-
eration of alternative primary surgical methods, or closer postoperative surveillance.
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Introduction
Primary congenital glaucoma (PCG) is a rare disease, occurring at a ratio of approxi-
mately 1:10,000 to 1:20.000 in newborns in Western countries, but it is responsible for 
2.5%–15% of all documented cases of pediatric blindness.1–4 Primary congenital glaucoma 
due to isolated trabeculodysgenesis is the most common etiology of infantile glaucoma, 
but other conditions such as Axenfeld–Rieger anomaly, Peters’ anomaly, Sturge–Weber 
syndrome, aphakia, aniridia, and uveitis may also result in secondary glaucoma.5
Therapy for congenital glaucoma is primarily surgical, and a number of dif-
ferent approaches have been proposed. Barkan first described goniotomy in 
1942.6   Trabeculotomy was popularized by several authors7–10 including Harms 
and Dannheim in 1970.11 A modified   360-degree trabeculotomy technique using 
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6–0 polypropylene suture (Prolene®; Ethicon Inc, New 
Brunswick, NJ) was reported by Beck and Lynch in 1995, 
with high surgical success rates compared to conventional 
(180°) procedures.12
The early literature centered on whether goniotomy or 
trabeculotomy is the better primary approach, and although 
each has its own advantages and shortcomings, these two 
methods are now felt to be roughly equivalent for controlling 
intraocular pressure (IOP), at least in the setting of a clear 
cornea.14–16 Nevertheless, Mendicino et al suggested that the 
360-degree suture trabeculotomy technique may yield better 
visual outcomes than goniotomy.17
The reported long-term success rates of trabeculotomy 
have generally been high, but those numbers typically come 
from centers or individual surgeons with high volumes and 
experience. The number of reports evaluating long-term 
surgical outcomes, both with respect to congenital glaucoma 
in general and trabeculotomy in particular, is limited.18–22 
For example, among 17 eyes of eleven patients undergoing 
primary trabeculotomy, Dietlein et al report success rates 
of 77%, 59%, and 53% at 6 months, 2 years, and 5 years, 
respectively.18 Akimoto et al examined 116 eyes and cite 
5- and 10-year surgical success rates of 62.9% and 51.5%, 
respectively, for initial trabeculotomy, and total 5- and 
10-year success probabilities of 92.5% and 76.5%, respec-
tively, for one or more trabeculotomies.19 Similarly, Ikeda 
et al report 5- and 10- year success rates of 94.3% and 87.7%, 
respectively, after the first trabeculotomy among 112 eyes 
with primary developmental glaucoma.22
Long-term outcome data from the United States remains 
sparse, and more recent reports tend to address newer and 
combined techniques.23–31 The purpose of this report is to 
analyze long-term outcomes for a pseudo 360-degree trabe-
culotomy technique, using conventional Harms probes, at 
Children’s Medical Center in Dallas.
Patients and methods
This study was approved by the Institutional Review Boards 
of both the University of Texas Southwestern Medical 
Center and Children’s Medical Center of Dallas (CMC) as 
a retrospective chart review. Charts were located through 
an International Statistical Classification of Diseases and 
Related Health Problems (ICD-9) and Current Procedural 
Terminology (CPT) database search at CMC, looking for 
patients/eyes that met the following criteria: (1) carried a 
diagnosis of congenital glaucoma, either in the medical 
record, or on the basis of ICD-9 coding for glaucoma of child-
hood (365.14); (2) had undergone trabeculotomy surgery 
(CPT procedure code 65850) performed at CMC between 
June 1, 1992 and December 31, 2005.
After identifying patients/eyes based on these inclu-
sion criteria, charts were manually reviewed and eyes 
were excluded based upon the following exclusion criteria: 
(1)   trabeculotomy performed at another institution prior to 
referral to CMC; (2) less than a minimum 1-year follow-up 
from the time of surgery to most recent examination; 
(3)   presence of any comorbid congenital ocular pathologies, 
other than congenital or secondary glaucoma, that might 
affect the success of trabeculotomy surgery with respect to 
ultimate visual outcome (eg, persistent hyperplastic primary 
vitreous, retinopathy of prematurity, Coat’s disease); (4) eyes 
with Peters’ anomaly that underwent trabeculotomy but 
subsequently required corneal transplant within the first five 
years of follow-up – as the effects of secondary glaucoma 
after penetrating keratoplasty (PK) cannot clearly be sepa-
rated from primary failure of the trabeculotomy.
Syndromes and systemic disorders predisposing to con-
genital glaucoma (eg, Down syndrome, Turner syndrome, 
Lowe syndrome, Stickler syndrome, and Zellweger syn-
drome) were not specifically excluded. Likewise,   strabismus 
and amblyopia alone were not considered criteria for 
exclusion. There were no sex, race, or other demographic 
criteria used for inclusion/exclusion.
The surgical technique employed in all cases begins in 
the superonasal quadrant with a 90-degree limbal   peritomy; 
  dissection of a partial thickness, limbus-based scleral flap 
(either triangular or trapezoidal); a radial cut-down to 
Schlemm’s canal; rotation of Harms trabeculotomes in each 
direction through the trabecular meshwork and into the anterior 
  chamber; maintenance of anterior chamber depth through injec-
tion of viscoelastic through a temporal paracentesis; closure of 
the scleral flap (typically with a 10–0 nylon suture); closure of 
the conjunctiva at the limbus (typically with 8–0 vicryl); and 
repetition of the procedure in the inferotemporal quadrant, 
  following rotation of the microscope 180 degrees away from 
the first position. In other words, two separate 120- to 180-
degree Harms trabeculotomies are performed simultaneously 
at the same sitting. We have dubbed this a “pseudo 360-degree” 
technique. At the conclusion of the procedure, subconjunctival 
injections of antibiotic and steroid are administered, and the 
eye is dressed with antibiotic or combination antibiotic-steroid 
ointment, followed by a patch and overnight shield. The postop-
erative treatment regimen includes topical antibiotic (typically a 
fluoroquinolone) four times daily for 1 week and prednisolone 
acetate, beginning at four times daily with a slow taper over 
approximately 6 weeks.
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Among eyes included for study, the following parameters 
were recorded: (1) etiology of glaucoma; (2) date of surgery; 
(3) age at the time of surgery; (4) nature of procedure and any 
intraoperative complications noted in the operative report; 
(5) total follow-up time between surgery and most recent 
examination; (6) any significant peri- and postoperative 
  complications; (7) initial (eg, at the time of glaucoma diagno-
sis and/or examination under anesthesia with   trabeculotomy), 
(8) final, and (9) net change in cup-to-disk ratio (C:D); 
(10) initial, (11) final, and (12) net change in IOP; (13) IOP 
just prior to any secondary surgical intervention; (14) corneal 
diameter, and (15) any change in corneal diameter throughout 
the course of follow-up; (16) total number and (17) type of 
medications required post trabeculotomy; (18) number, and 
(19) type of any secondary surgical interventions; (20) final 
visual acuity outcome, and (21) performance, on any visual 
field testing. Virtually all IOP and C:D data were recorded 
from examinations under anesthesia during the follow-up 
period (due to patient age). IOP was measured just after 
induction of general anesthesia using a hand-held Tono-Pen® 
XL applanation tonometer (Reichert Technologies, Depew, 
NY). For tabulation purposes, fixed-combination drops, such 
as dorzolamide–timolol, were counted as two drugs.
Failure of primary trabeculotomy was defined as per-
sistent IOP . 30 mmHg on two or more medications, or 
IOP . 30 mmHg on less than two medications with sufficient 
C:D progression to warrant additional surgical intervention. 
For the purpose of this analysis, cycloablation was considered 
surgical intervention, and thus grounds for failure. Complete 
surgical success was achieved if IOP , 21 mmHg was main-
tained over the course of follow-up, without the need for 
additional medical therapy. Otherwise, surgery was deemed 
a partial (or incomplete) success. Corneal diameter measure-
ments were inconsistent, and in no case was corneal diameter 
found to change by $1.0 mm over the course of follow-up. 
Therefore, change/progression in corneal diameter alone was 
not used as a criterion to determine surgical success.
Outcomes were then evaluated based upon surgical suc-
cess, type of glaucoma, age at the time of surgery, and final 
visual outcome. Statistical analyses were performed using 
SigmaStat® (Systat® Software, Chicago, IL). Data is expressed 
as mean ± standard error of the mean (SEM). Univariate sta-
tistical analysis was performed using one-way analysis of 
variance (ANOVA), with Holm–Sidak multiple comparisons, 
where applicable, or two-tailed Student’s t-test for continuous 
data. Kruskal–Wallis one-way ANOVA on ranks was used if 
and when the normality test failed.   Chi-squared, with Yates’ 
correction, where applicable, or Fisher’s exact test were used 
for normative data.   Multivariate analysis was performed via 
two-way ANOVA. MedCalc v 9.5.2.0 (MedCalc Software, 
Mariakerke, Belgium) was used to generate Kaplan–Meier 
success probability curves for life table and survival prob-
ability analyses. A P value of < 0.05 was considered statisti-
cally significant.
Results
Study cohort
The database query generated 36 patient charts for review. 
Of these, 21 eyes of twelve patients were excluded, as shown 
in Table 1. Thirty-eight eyes of 24 patients who underwent 
trabeculotomy between June 9, 1992 and November 22, 
2005 were then included in the study. In 14 cases (58.3%), 
bilateral trabeculotomies were performed, where both eyes 
met study criteria. All charts had operative reports available 
for review. No operative reports indicated any difficulty in 
locating Schlemm’s canal and passing the Harms probes, 
or that any less than four passes of the probes (one in each 
direction at each of the two cut-down sites) were performed. 
Thirty-six of 38 eyes were operated on by the same primary 
surgeon.
Table 2 shows the baseline demographics of eyes in the 
study cohort, including sex, laterality, age at time of   surgery, 
and mean follow-up time. Seven eyes were operated on after 
1 year of age. Glaucoma subtypes are indicated in Figure 1. 
Of note, two patients with uncommon presentations of 
Sturge–Weber syndrome (SWS) with bilateral glaucoma 
were included.
Surgical complications
There were no documented complications attributed to 
the trabeculotomy. No eyes exhibited prolonged hyphema, 
hypotony, or choroidal effusions lasting beyond the first 
month postoperatively. One eye developed a vitreous hemor-
rhage, secondary to trauma that occurred in the first 2 months 
postoperatively, that cleared without surgical intervention.
Surgical success analysis
Mean IOP at the time of glaucoma diagnosis was 32.7 ± 1.1 mmHg. 
Final IOP (after trabeculotomy, medication, and any additional 
surgical intervention) averaged 17.9 ± 0.8 mmHg at most 
Table 1 Reasons for study exclusion
Trabeculotomy not performed at CMC 7 patients (13 eyes)
Insufficient follow-up (,1 year) 2 patients (2 eyes)
Peters’ anomaly with PK following trabeculotomy 1 patient (2 eyes)
Unable to locate chart 2 patients
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
691
360-degree trabeculotomy: long-term infant outcomesClinical Ophthalmology 2012:6
recent follow-up. With trabeculotomy and medication alone, 
mean postoperative IOP was 19.9 ± 1.1 mmHg, with a mean 
drop in IOP of 12.5 ± 1.4 mmHg.
Prostaglandin analogues were the most common agents 
used for IOP control, followed by carbonic anhydrase inhibi-
tors and beta-blockers. Surgical success, defined by sufficient 
IOP control with primary trabeculotomy and medication 
alone, was achieved in 30 eyes (78.96%). One eye, with a 
final IOP of 25 mmHg, on monotherapy, and subsequently 
lost to follow-up, could not adequately be labeled as either 
a success or failure. No other eyes fell into this intermediate 
zone, with IOP in the 21–30 range. Seventeen eyes (44.7% 
of all eyes; 56.7% of successful eyes) achieved complete 
success. Among eyes with partial surgical success, mean 
time to initiate medical therapy was 15.5 ± 6.9 months 
postoperatively. The mean number of medications at last 
follow-up was 1.4 ± 0.2.
Seven eyes (18.4%) in five patients failed primary trabe-
culotomy, six based upon a postoperative IOP .30 mmHg 
on two or more medications, and one based upon a C:D 
ratio of 0.95, and persistent IOP .30 mmHg at 3 months 
postoperatively, prompting additional intervention. Mean 
time to failure was 46.9 ± 8.6 months postoperatively 
(range 11.7–66.9 months). Among those who failed pri-
mary trabeculotomy, 1.6 ± 0.5 additional surgeries (range 
0–3) were performed. Table 3 lists the secondary surgeries 
performed on eyes in the failure group. Of note, the parents 
of one patient with bilateral failure, and documented poor 
0
01 22 43 64 86 07 28 49 6 108 120
10
20
30
40
50
60
70
80
90
100
S
u
c
c
e
s
s
 
p
r
o
b
a
b
i
l
i
t
y
 
%
Survival time (Months)
Figure 1 Kaplan–Meier success probability survival curve for primary trabeculotomy at CMC.
Note: Trabeculotomy was performed at the Children’s Medical Center, Dallas, TX.
Table 2 Baseline demographics of study cohort
Gender 13 M (54.2%), 11 F (45.8%)
Laterality 18 OD (47.4%), 20 OS (52.6%), 14 OU (58.3%)
Age at the time  
of surgery
11.1 ± 3.0 months (range 0.3–102.5 months)
Follow-up time 85.1 ± 9.0 months (range 16.6–199.4 months)
Abbreviations: M, male; F, female; OD, left eye; OS, right eye; OU, both eyes.
compliance with medical therapy, declined any further 
intervention, and there are no current plans for additional 
surgery.
Among the 14 patients in whom both eyes were included 
in the study, nine (64.3%) achieved bilateral surgical success, 
and two (14.3%) had bilateral failure. As discussed below, 
both of these patients represented uncommon presentations 
of SWS with bilateral glaucoma, and both demonstrated 
poor compliance with medical therapy. Of the nine patients 
with bilateral surgical success, seven (77.8%) had complete 
success in both eyes. Three patients (21.4%) had one eye that 
failed and one that had partial success.
Eyes that achieved surgical success, and those that failed, 
are compared, using multiple parameters, in Table 4. Simi-
larly, complete and incomplete successes are compared in 
Table 5. The final C:D ratio was significantly higher among 
eyes that failed surgery, compared to those that achieved 
surgical success (0.71 ± 0.08 vs 0.47 ± 0.04; P = 0.018). 
Eyes that failed surgery had a mean increase in C:D ratio 
(0.13 ± 0.07) over the course of follow-up, which compares 
to a mean decrease in C:D ratio (−0.10 ± 0.04) among those 
which achieved surgical success (P = 0.007). Similarly, eyes 
achieving complete success had lower mean C:D ratios 
(0.36 ± 0.03 vs 0.61 ± 0.56; P , 0.001) and less C:D ratio 
progression (−0.16 ± 0.04 vs 0.01 ± 0.06; P = 0.028) than 
those with incomplete success. By definition, IOP on medi-
cation alone was higher in the failure group (P , 0.001), 
as was the IOP response to medication alone among the 
surgical success group (P , 0.001). There were no differ-
ences in initial C:D ratio, initial IOP, corneal diameter, age 
at trabeculotomy, or follow-up time, either with respect 
to success vs failure, or complete vs incomplete success. 
Although no eyes operated on after 12 months of age went 
on to achieve complete success, there was no difference in 
failure rates between infantile and older eyes (P = 0.608).
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Table 3 Secondary surgeries among eyes that failed primary 
trabeculotomy
Eye Patient No surgeries Secondary surgeries
1 1 3 Cyclocryo therapy × 3
2 2 2 Cyclodiode, Ahmed tube shunt
3 3 3 Cyclodiode, Baerveldt tube 
shunt, cyclodiode
4 4 2 Ahmed tube shunt, cyclodiode
5 2 Ahmed tube shunt, cyclodiode
Table 4 Comparison of surgical success vs failure
Variable Success Failure P
n (%) 30 (78.95%) 7 (18.4%)
Age at TAE 
(months)
11.79 ± 3.84 9.37 ± 3.81 0.469
Follow-up 
(months)
80.41 ± 10.72 93.28 ± 14.63 0.257
initial C:D 0.55 ± 0.04 0.58 ± 0.08 0.742
Final C:D 0.47 ± 0.04 0.71 ± 0.08 0.018*
ΔC:D −0.10 ± 0.04 +0.13 ± 0.07 0.007*
initial iOP (mmHg) 32.16 ± 1.06 36.14 ± 2.76 0.124
Final iOP (mmHg) 16.63 ± 0.50 23.57 ± 3.54 0.126
iOP meds alone 
(mmHg)
16.63 ± 0.50 33.21 ± 0.62 ,0.001*
ΔiOP net (mmHg) −15.59 ± 1.12 −12.57 ± 4.55 0.509
ΔiOP meds alone 
(mmHg)
−15.59 ± 1.12 −2.93 ± 2.61 ,0.001*
Corneal diameter 
(mm)
13.36 ± 0.34 13.15 ± 0.17 0.570
No medications 0.60 ± 0.16 1.43 ± 0.37 0.065
Notes: *P , 0.05 was considered statistically significant.
Abbreviations:  TAE,  trabeculotomy  ab  externo;  C:D,  cup-to-disk  ratio;  iOP, 
intraocular pressure.
Kaplan–Meier survival curve analysis was performed 
and is shown in Figure 2. Accompanying life table analysis 
is shown in Table 6. Five- and 10-year survival   probabilities 
for primary trabeculotomy were 93.1% ± 0.05% and 
66.8% ± 0.11%, respectively.
Among surgical successes, 5- and 10-year survival rates 
for complete success were 55.9% ± 0.1% and 46.6% ± 0.1%, 
  respectively, as shown in Figure 3 (life table analysis not shown).
Outcomes by glaucoma etiology
For the purpose of data analysis, the eye with Rieger anomaly 
was grouped with the SWS eyes under the rubric of “sec-
ondary glaucomas due to ocular anomalies”. Comparisons 
between multiple parameters are shown in Table 7. The 
proportion of eyes with secondary glaucoma that went on 
to fail was significantly higher than those with congenital or 
aphakic glaucoma (P = 0.009). They were also less likely to 
achieve complete success (P = 0.02). Additionally, these eyes 
were more likely to demonstrate C:D progression, higher IOP, 
and less IOP response to treatment. As a consequence, they 
required more medications by the time of most recent follow-
up. In all cases where a statistically significant difference 
between groups was found, the difference was attributable 
to the difference between the congenital glaucoma group 
and those with SWS. There were no differences in age at the 
time of trabeculotomy, the initial or final C:D ratio, initial 
IOP, corneal diameter, number of secondary surgeries, or 
total follow-up time.
Kaplan–Meier survival curves by glaucoma type are 
shown in Figure 4. Cox proportional hazards regression 
analysis suggests an instantaneous relative risk of failure 
of 5.81 (95% confidence interval: 1.24–27.26; P = 0.026) 
associated with anomalous secondary glaucoma (SWS or 
Rieger anomaly), as compared with congenital glaucoma or 
aphakic glaucoma.
Multivariate analysis with two-way ANOVA demonstrated 
a statistically significant interaction between success and glau-
coma type with respect to final IOP (P , 0.001) and response 
to IOP on medications alone (P = 0.038). Hence, the differ-
ences noted in Table 4, between success and failure among 
these two parameters, could be explained by differences in 
glaucoma type: the disproportionate tendency for eyes in the 
Sturge–Weber/Rieger group to fail primary trabeculotomy.
Compliance with follow-up
After noting that four of seven surgical failures were gener-
ated from only two patients with bilateral SWS-related glau-
coma, we suspected that poor compliance with medication 
and/or follow-up may have played a role in those outcomes. 
Using average number of follow-up visits per year as a sur-
rogate for compliance, no statistically significant relation-
ships were identified between follow-up rates and outcomes 
Table 5 Comparison of complete vs incomplete surgical success
Variable Complete Incomplete P
n (%) 17 (56.7%) 13 (43.3%)
Age at TAE (months)   11.79 ± 3.84 9.37 ± 3.81 0.469
Follow-up (months)   71.74 ± 12.69 90.41 ± 18.02 0.381
initial C:D     0.54 ± 0.06 0.57 ± 0.06 0.678
Final C:D     0.36 ± 0.03 0.61 ± 0.56 ,0.001*
ΔC:D  − 0.16 ± 0.04 +0.01 ± 0.07 0.028*
initial iOP (mmHg)   32.07 ± 1.67 32.27 ± 1.32 0.926
Final iOP (mmHg)   16.12 ± 0.59 17.31 ± 0.84 0.245
ΔiOP (mmHg) −16.13 ± 1.66 −14.96 ± 1.53 0.612
Corneal diameter (mm)   13.38 ± 0.22 12.91 ± 0.24 0.148
Notes: *P , 0.05 was considered statistically significant.
Abbreviations:  TAE,  trabeculotomy  ab  externo;  C:D,  cup-to-disk  ratio;  iOP, 
intraocular pressure.
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Figure 2 Kaplan–Meier curve for complete success.
(  success vs failure), when analyzed across several time 
periods (see Table 8). However, eyes that achieved complete 
success ultimately required slightly fewer follow-up visits 
per year after the first postoperative year than those with 
incomplete success. Although some of these patients were 
also followed-up separately by the general pediatric ophthal-
mology team for ongoing treatment of amblyopia, strabis-
mus, and other comorbid ocular conditions, only scheduled 
follow-up appointments with our glaucoma specialist were 
considered in this analysis.
We then looked specifically at the same measurements 
in eyes with SWS compared to those with PCG. Eyes with 
SWS had significantly fewer follow-up visits in the first 
postoperative year (Table 9). Assessment of follow-up in the 
SWS cohort was limited after 5 years postoperatively, as only 
one eye had follow-up extending to 10 years, and that patient 
returned at year 10, after 4 years without follow-up.
Final visual outcomes
Lastly, an attempt was made to evaluate functional surgical 
outcomes based upon final visual acuity and performance 
using automated Humphrey visual field testing.   Snellen 
acuities were able to be quantified in 27 of 38 eyes (71.1%). 
Of the remaining eleven eyes, two were deemed to have 
amblyopia, based upon poor maintenance of fixation, and 
two had marked nystagmus, in one patient with Down 
syndrome and aphakia. All four of these eyes were incom-
plete surgical successes. The remainder were evaluated 
by the central, steady, maintained (CSM) conventional 
nomenclature, and were found to be normal on all three 
parameters. Among the eleven eyes, eight had congenital 
glaucoma, and three had aphakic glaucoma. The number of 
eyes in this group was too small to derive any meaningful 
relationships.
The 27 eyes in which a final Snellen best-corrected visual 
acuity score could be obtained were stratified into three 
visual outcome groups: 20/20–20/40, 20/50–20/200, and 
#20/400. These three groups were compared along multiple 
parameters, as shown in Table 10.
Those eyes with poor visual outcomes #20/400 were 
found to have significantly higher initial C:D (P = 0.028), 
final C:D ratio (P = 0.005), and corneal diameter (P = 0.043), 
compared to the other two groups. They also exhibited a much 
larger decrease in IOP from the time of trabeculotomy to the 
most recent follow-up (P = 0.03). There were no differences 
between the groups with respect to age at trabeculotomy, 
follow-up time, initial or final IOP, number of medications 
required in the postoperative period, proportion of surgical 
success vs failure, or distribution of glaucoma subtypes 
within each.
Table 6 Life table analysis
Follow-up 
(months)
No eyes  
at risk
No failures No lost to  
follow-up
Survival 
proportion 
(% ± SE)
6 35 0 0   100 ± 0.0
12 34 1 0 97.1 ± 0.03
24 32 0 2 97.1 ± 0.03
36 26 0 6 97.1 ± 0.03
48 20 1 5 93.1 ± 0.05
60 19 0 1 93.1 ± 0.05
72 12 5 2 66.8 ± 0.11
84 10 0 2 66.8 ± 0.11
96 10 0 0 66.8 ± 0.11
108 10 0 0 66.8 ± 0.11
120 7 0 3 66.8 ± 0.11
Abbreviation: SE, standard error.
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Figure 3 Kaplan–Meier success probability curves by type of glaucoma.
Abbreviations: CG, Congenital Glaucoma; SWS, Sturge–Weber Syndrome.
Unilaterally affected cases were also examined, given 
the increased risk of amblyopia in these eyes. Of the 27 
eyes with available Snellen acuity data, nine had unilateral 
glaucoma. Of those, five (56%) were 20/40 or better, and 
four (44.4%) were 20/25 or 20/20 at most recent follow-up. 
Two eyes (22.2%) were in the poorest visual outcome 
(#20/400) group.
Discussion
Pediatric glaucoma remains a challenging problem for the 
ophthalmologist. Eyes with this disorder often require a com-
bination of medications and surgery for optimal IOP control. 
At our medical center, primary trabeculotomy, using a traditional 
Harms’ probe for pediatric glaucoma, provides   respectable 
surgical success rates: 78.95% overall; 93.1 ± 0.05% at 5 years, 
and 66.8 ± 0.11% at 10 years. Moreover, 56.7% of those who 
achieved success required no additional medical therapy to main-
tain IOP at acceptable levels. In addressing a wider degree of 
the trabecular dysgenesis than a standard 180-degree procedure, 
our pseudo 360-degree technique may have accounted for these 
outcomes. This technique compares well with the 85%–92% 
success rates at 3–4 years reported for a 360-degree trabeculo-
tomy with a 6–0 Prolene suture,12,17 as well as for those reported 
for combined trabeculotomy/trabeculectomy.25–30
Table 7 Comparison of outcomes by glaucoma type
PCG Anomalies 
(SWS and AR)
Aphakic P
n (%) 27 (71.1%) 7 (18.4%) 4 (10.5%)
Age at TAE (months) 12.46 ± 4.14 10.17 ± 4.77 4.82 ± 0.28 0.502
Follow-up (months) 86.1 ± 11.77 86.97 ± 14.40 75.7 ± 29.15 0.758
initial C:D 0.58 ± 0.05 0.54 ± 0.04 0.47 ± 0.09 0.629
Final C:D 0.50 ±0.04 0.67 ± 0.06 0.44 ± 0.11 0.085
Δ C/D −0.01 ± 0.04 0.14 ± 0.08 −0.02 ± 0.1 0.023*
initial iOP (mmHg) 32.48 ± 1.17 32.14 ± 2.68 36.63 ± 5.42 0.936
Final iOP (mmHg) 15.96 ± 0.52 25.14 ± 2.88 20.5 ± 1.66 0.003*
iOP meds alone (mmHg) 17.59 ± 1.03 26.36 ± 3.24 24.25 ± 3.25 0.003*
ΔiOP net (mmHg) −16.64 ± 1.29 −7.0 ± 2.44 −13.13 ± 6.96 0.017*
ΔiOP meds alone (mmHg) −14.88 ± 1.45 −5.79 ± 2.97 −9.38 ± 5.73 0.027*
Corneal diameter (mm) 13.33 ± 0.18 12.83 ± 0.17 12.5 ± 0.5 0.102
No medications 0.4 ± 0.15 1.86 ± 0.26 1.50 ± 0.29 ,0.001*
No surgeries 0.2 ± 0.14 0.71 ± 0.47 0.25 ± 0.25 0.28
Failures 2 (7.4%) 4 (57.1%) 1 (25%) 0.009*
Success 25 (92.6%) 3 (42.9%) 2 (50%)
Complete success 17 (68%) 0 (0%) 0 (0%) 0.02*
incomplete success 8 (32%) 3 (100%) 2 (100%)
Notes: *P , 0.05 was considered statistically significant.
Abbreviations: TAE, trabeculotomy ab externo; C:D, cup-to-disk ratio; iOP, intraocular pressure; SWS, Sturge–Weber syndrome; AR, Axenfeld–Rieger anomaly.
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Table 8 Mean follow-up visits per year vs outcome
Success Failure P
Complete Incomplete
Year 1 3.0 ± 0.2 2.3 ± 0.5 0.08
2.8 ± 0.2 3.2 ± 0.3 0.22
Years 1–5 1.6 ± 0.4 1.2 ± 0.3 0.37
1.3 ± 0.4 1.9 ± 0.4 0.29
Years 2–most  
recent exam
1.0 ± 0.1 1.1 ± 0.2 0.91
0.8 ± 0.1 1.2 ± 0.1 0.02
Duration of  
follow-up
1.2 ± 0.2 1.3 ± 0.3 0.70
0.9 ± 0.2 1.3 ± 0.2 0.10
This retrospective outcome review also highlights a dis-
parity in response to primary trabeculotomy between glau-
coma subgroups. Eyes with SWS had a much more limited 
response, with a higher failure rate and relative risk of failure 
of 5.81, more C:D progression, higher IOP (both on medica-
tion alone and after additional surgical interventions), and 
less IOP response to treatment. As a consequence, these eyes 
required significantly more medications by the time of most 
recent follow-up. While our series has a limited number of 
cases of SWS, our findings are comparable with results from 
larger series of eyes with SWS, as have been reported in the 
literature.22 It has been hypothesized that the pathophysiol-
ogy of Sturge–Weber syndrome – elevated episcleral venous 
pressure downstream to Schlemm’s canal in the aqueous 
outflow pathway – may render such eyes less amenable to 
modification of the trabecular meshwork (ie, goniotomy/
trabeculotomy) as a surgical remedy for glaucoma.22,32–36 
In concert with our findings, Ikeda et al also found that eyes 
with secondary glaucomas have lower success probabilities 
at 5, 10, and 15 years, than those with primary developmen-
tal glaucoma, after trabeculotomies (82.2% vs 94.3% at   
5 years, 77.1% vs 87.7% at 10 years, and 64.2% vs 80.8% 
at 20 years).22 Furthermore, eyes with SWS fared the worst 
among those with secondary glaucomas, yielding the lowest 
success rates, highest mean IOPs, and largest proportion of 
eyes with poor visual acuity (,20/200).22
Standard trabeculectomy, or combined   trabeculotomy/
trabeculectomy, may be advantageous in SWS,   bypassing 
Schlemm’s canal and redirecting aqueous to the   subconjunctival 
space.35–39 However, filtering surgery in the pediatric popula-
tion is less likely to succeed. due to lower scleral rigidity and 
a rapid, often exuberant, healing response.40 Furthermore, the 
risk of complications, including expulsive hemorrhage, may 
be magnified in patients with SWS.39,41
Ethnicity may influence surgical success for congenital 
glaucoma. Elder found a 5-year success rate of 35% when 
t  rabeculotomy was performed on Palestinian Arab children by 
general ophthalmologists.42 When performed by a   specialist 
in the Middle East, Debnath et al reported a higher, but still 
  modest, 1-year success rate of only 67%.23 At their center 
in Ankara, Turkey, Yalvac et al reported better 12-, 24-, and 
36-month trabeculotomy success rates of 92%, 82%, and 
74%, respectively, on eyes operated on within 3 months of 
birth.43 Al-Hazmi et al suggest that success may be related 
to glaucoma severity (based upon IOP, corneal diameter, 
and corneal clarity).44 In their series from Saudi Arabia, they 
found a marginal 41% overall success rate for trabeculotomy 
among 418 eyes, but a 93% success rate among the 102 eyes 
  substratified as having mild glaucoma. There was a 65% 
  success rate among eyes with moderate glaucoma, and only 
a 15% success rate among those with severe glaucoma. In 
our series, glaucoma severity was not categorized as such, 
and there was no attempt made to stratify or compare patients 
by ethnicity.
Despite the achievement of surgical success with respect 
to IOP control (as it is traditionally defined), the visual prog-
nosis of patients with developmental glaucoma continues to 
be poor, with most reports indicating that less than half of 
these children achieve a final visual acuity of 20/50 or bet-
ter.20,21,29 This discrepancy highlights the confounding effect of 
amblyopia in pediatric glaucomas. In our series, 13 of 38 eyes 
(34.2%), representing 48.1% (13/27) of eyes with quantifiable 
Snellen acuity, achieved 20/40 or better, which is in concert 
with previous reports. Among eyes with unilateral glaucoma, 
which may be those most prone to amblyopia, 56% achieved 
a visual acuity of 20/40 or better at most recent follow-up.
27 eyes
(16 patients)
1 eye
(1 patient)
6 eyes
(4 patients)
4 eyes
(3 patients)
Primary congenital
glaucoma
Rieger's anomaly
Sturge−Weber syndrome
Aphakic glaucoma
Figure 4 Glaucoma subtype among study eyes.
Table 9 Mean follow-up visits per year, by glaucoma subtype
PCG 
(n = 27)
SWS 
(n = 6)
P
Year 1 3.0 ± 0.2 1.7 ± 0.4 0.001
Years 1–5 1.6 ± 0.4 1.0 ± 0.2 0.25
Years 2–5 1.2 ± 0.2 0.9 ± 0.2 0.18
Duration of follow-up 1.1 ± 0.2 1.1 ± 0.2 0.98
Abbreviations: PCG, Primary Congenital Glaucoma; SWS, Sturge–Weber Syndrome.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
696
Saltzman et alClinical Ophthalmology 2012:6
The differences found within the #20/400 visual acuity 
group were consistent with more aggressive and advanced 
glaucoma, indicated by higher initial and final C:D ratios and 
corneal diameters. Indeed, poor final visual acuity was the 
only outcome measure found to have any association with 
findings at initial glaucoma diagnosis, namely, C:D ratio. 
  Initial IOP had no correlation with surgical success, glau-
coma type, or visual outcome. The net decrease in IOP was 
also found to be higher within this group, likely reflecting 
more aggressive secondary surgical management, as evi-
denced by the fact that (1) initial IOPs were no higher in this 
group than the others, (2) the number of surgeries performed 
in this group was no higher, and (3) these eyes had a similar 
IOP response on medications alone (prior to any secondary 
surgery) compared to the other two visual outcome groups. 
Ultimately, there was no direct correlation between surgical 
success and the central visual acuity achieved.
Our study has several limitations, in particular, its 
retrospective design, the relatively small sample size, and 
the inconsistent availability of data for all variables across 
all study eyes. As with previous reports, outcomes in this 
study cohort suggest that eyes with aphakic glaucoma and 
Sturge–Weber syndrome may warrant consideration of 
alternative primary surgical methods, or closer postoperative 
surveillance. Overall, however, this review demonstrates 
that primary trabeculotomy with our technique compares 
  favorably with those reported in the literature. Further stud-
ies are needed to determine the most effective and safest way 
to treat this uncommon but often devastating disease.
Conclusions
Our long-term trabeculotomy success rates for congenital 
glaucoma compare favorably with existing reports in the 
literature. Eyes with AG and SWS may warrant consideration 
of alternative primary surgical methods, or closer postopera-
tive surveillance.
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